Title : Phenformin synergistically sensitizes liver cancer cells to sorafenib by downregulating CRAF/ERK and PI3K/AKT/mTOR pathways.

Pub. Date : 2021

PMID : 34377232






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Phenformin synergistically sensitizes liver cancer cells to sorafenib by downregulating CRAF/ERK and PI3K/AKT/mTOR pathways. Sorafenib AKT serine/threonine kinase 1 Homo sapiens
2 Phenformin further bolstered the ability of sorafenib to inhibit the CRAF/ERK and PI3K/AKT/mTOR pathways. Sorafenib AKT serine/threonine kinase 1 Homo sapiens
3 Sorafenib and phenformin can synergistically suppress CRAF/ERK and PI3K/AKT/mTOR pathway activation in HCC cells, and may thus represent a promising approach to treating this deadly cancer. Sorafenib AKT serine/threonine kinase 1 Homo sapiens